首页> 外文期刊>Journal of proteomics >Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches
【24h】

Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches

机译:过氧化毒素-2和锌-α-2-糖蛋白作为可能组合的新型唾液生物标志物,用于使用蛋白质组学方法早期检测口腔鳞状细胞癌

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract No effective screening method is available for oral squamous cell carcinoma (OSCC) that is recognized to influence by environmental factors as well as human papillomavirus (HPV) and Epstein-Barr virus (EBV). Therefore, we sought to identify salivary biomarkers for screening of OSCC with or without HPV and/or EBV infection. Saliva, lesion and oral exfoliated cells were collected from OSCC patients and cancer-free controls (CFCs) and grouped depending on their HPV- and EBV-infection status. Salivary protein was precipitated and subjected to 2-dimensional gel electrophoresis. Differential expression of proteins was identified by mass spectrometry and validated by Western blotting. Distinctive expression patterns of salivary proteins were detected in OSCC as compared with CFCs. Levels of peroxiredoxin-2 (PRDX-2) and zinc-alpha-2-glycoprotein (ZAG) were significantly up-regulated in OSCC cases (p Significance Our findings demonstrate a useful of combined detection of PRDX-2 and ZAG as a salivary biomarker for the early detection of OSCC. Graphical abstract Display Omitted Highlights ? 7 proteins that differentially expressed were identified using mass spectrometry. ? PRDX-2, ZAG, HP were significantly up-regulated in saliva of OSCC cases. ? PRDX-2 and ZAG were also up-regulated in lesion of OSCC cases. ? PRDX-2 and ZAG yielded a highest discriminatory power in distinguishing OSCC patients from CFCs. ? Combination of salivary PRDX-2 and ZAG could be useful as the biomarker for OSCC.
机译:摘要没有有效的筛选方法可用于口腔鳞状细胞癌(OSCC),该鳞状细胞癌(OSCC)被认为是由环境因素和人乳头瘤病毒(HPV)和Epstein-Barr病毒(EBV)的影响。因此,我们试图鉴定唾液生物标志物,用于筛选随机或没有HPV和/或EBV感染的OSCC。从OSCC患者和无癌症对照(CFC)收集唾液,病变和口腔脱落细胞,并根据其HPV和EBV-infection身份进行分组。唾液蛋白沉淀并进行二维凝胶电泳。通过质谱法鉴定蛋白质的差异表达,并通过Western印迹验证。与CFC相比,在OSCC中检测到唾液蛋白的独特表达模式。在OSCC病例中显着上调过氧化毒素-2(PRDX-2)和锌-α-2-糖蛋白(ZAG)的水平(P意识我们的研究结果证明了将PRDX-2和ZAG的组合检测为唾液生物标志物用于早期检测OSCC。图形摘要显示显示省略了差异表达的7种蛋白质,使用质谱法鉴定出差异表达的蛋白质。β-2,ZAG,HP在OSCC病例的唾液中显着上调。?PRDX-2和ZAG在OSCC病例的病变中也有上调。αPRDX-2和ZAG在区分OSCC患者中产生最高的歧视性,唾液PRDX-2和ZAG的组合可用作OSCC的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号